The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Spirocyclic Scaffolds in Medicinal Chemistry
Open accessAbstract
Spirocyclic scaffolds are incorporated in various approved drugs and drug candidates. The increasing interest in less planar bioactive compounds has given rise to the development of synthetic methodologies for the preparation of spirocyclic scaffolds. In this Perspective, we summarize the diverse synthetic routes to obtain spirocyclic systems. The impact of spirocycles on potency and selectivity, including the aspect of stereochemistry, is discussed. Furthermore, we examine the changes in physicochemical properties as well as in in vitro and in vivo ADME using selected studies that compare spirocyclic compounds to their nonspirocyclic counterparts. In conclusion, the value of spirocyclic scaffolds in medicinal chemistry is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Corey, E. J., & Chaykovsky, M. (1965) · Journal of the American Chemical Society · doi:10.1021/ja01084a034 · Cited by 1,584
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065
The use of spirocyclic scaffolds in drug discovery
Zheng, Y., Tice, C. M., & Singh, S. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.081 · Cited by 1,036
Gehringer, M., & Laufer, S. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 714
Caenepeel, S., Brown, S. P., Belmontes, B., Moody, G., Keegan, K. S., Chui, D., Whittington, D. A., Huang, X., Poppe, L., Cheng, A. C., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0387 · Cited by 432
Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon
Talele, T. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00829 · Cited by 424
Fsp3: A new parameter for drug-likeness
Wei, W., Cherukupalli, S., Jing, L., Liu, X., & Zhan, P. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.017 · Cited by 421
Ubrogepant for the Treatment of Migraine
Dodick, D. W., Lipton, R. B., Ailani, J., Lu, K., Finnegan, M., Trugman, J. M., & Szegedi, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813049 · Cited by 349
The utilization of spirocyclic scaffolds in novel drug discovery
Zheng, Y.-J., & Tice, C. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1195367 · Cited by 299
Spirocyclic Motifs in Natural Products
Chupakhin, E., Babich, O., Prosekov, A., Asyakina, L., & Krasavin, M. (2019) · Molecules · doi:10.3390/molecules24224165 · Cited by 247
Self-citationTarget discovery in small-molecule cell-based screens by in situ proteome reactivity profiling
Evans, M. J., Saghatelian, A., Sorensen, E. J., & Cravatt, B. F. (2005) · Nature Biotechnology · doi:10.1038/nbt1149 · Cited by 230
Chen, X.-T., Pitis, P., Liu, G., Yuan, C., Gotchev, D., Cowan, C. L., Rominger, D. H., Koblish, M., DeWire, S. M., Crombie, A. L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4010829 · Cited by 208
The evolution of aldosterone antagonists
Garthwaite, S. M., & McMahon, E. G. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.005 · Cited by 189
Recent progress in sodium channel modulators for pain
Bagal, S. K., Chapman, M. L., Marron, B. E., Prime, R., Storer, R. I., & Swain, N. A. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.038 · Cited by 177
Reich, S. H., Sprengeler, P. A., Chiang, G. G., Appleman, J. R., Chen, J., Clarine, J., Eam, B., Ernst, J. T., Han, Q., Goel, V. K., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01795 · Cited by 175
Ohtake, Y., Sato, T., Kobayashi, T., Nishimoto, M., Taka, N., Takano, K., Yamamoto, K., Ohmori, M., Yamaguchi, M., Takami, K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300884k · Cited by 174
Charting Biologically Relevant Spirocyclic Compound Space
Müller, G., Berkenbosch, T., Benningshof, J. C. J., Stumpfe, D., & Bajorath, J. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201604714 · Cited by 156
Conception and pharmacodynamic profile of drospirenone
Elger, W. A. G., Beier, S., Pollow, K., Garfield, R. E., Shi, S. Q., & Hillisch, A. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.008 · Cited by 142
Soupart, A., Gross, P. A., Legros, J., Diaeresis]ldi, S. A. A. A., Annane, D., Heshmati, H. M., & Decaux, G. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00160106 · Cited by 142
Boronated tartrolon antibiotic produced by symbiotic cellulose-degrading bacteria in shipworm gills
Elshahawi, S. I., Silva, A. E. T., Hanora, A., Han, A., Flores, M. S., Vizzoni, V. F., Schrago, C. G., Soares, C. A. G., Concepción, G. P., Distel, D. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213892110 · Cited by 130
Sampson, P. B., Liu, Y., Patel, N. K., Fehér, M., Forrest, B., Li, S.-W., Edwards, L. G., Laufer, R. S., Lang, Y., Ban, F., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500537u · Cited by 116
Wang, J., Lou, P., & Henkin, J. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000601)77:3<465::aid-jcb11>3.0.co;2-m · Cited by 103
Tofogliflozin: First Global Approval
Poole, R. M., & Prossler, J. E. (2014) · Drugs · doi:10.1007/s40265-014-0229-1 · Cited by 100
Ej, H., Norman, A., & Creese, I. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-07-02361.1988 · Cited by 99
Markham, A. (2020) · Drugs · doi:10.1007/s40265-020-01414-9 · Cited by 98
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors
Bagdanoff, J. T., Chen, Z., Acker, M., Chen, Y., Chan, H., Dore, M., Firestone, B., Fodor, M., García‐Fortanet, J., Hentemann, M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01725 · Cited by 95
Griffith, D. A., Kung, D. W., Esler, W. P., Amor, P. A., Bagley, S. W., Beysen, C., Carvajal‐Gonzalez, S., Doran, S. D., Limberakis, C., Mathiowetz, A. M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5016022 · Cited by 93
Spirolactones: Recent Advances in Natural Products, Bioactive Compounds and Synthetic Strategies
Quintavalla, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666171106162259 · Cited by 89
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors
Sarver, P., Acker, M., Bagdanoff, J. T., Chen, Z., Chen, Y.-N., Chan, H., Firestone, B., Fodor, M., Fortanet, J., Hao, H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01726 · Cited by 87
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles
Wang, Y., Liu, J., Dransfield, P. J., Zhu, L., Wang, Z., Du, X., Jiao, X., Su, Y., Li, A., Brown, S. P., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300427u · Cited by 87
Mallinger, A., Crumpler, S., Pichowicz, M., Waalboer, D., Stubbs, M., Adeniji-Popoola, O., Wood, B., Smith, E. L., Thai, C., Henley, A. T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501436m · Cited by 83
Tamura, T., Noda, H., Joyashiki, E., Hoshino, M., Watanabe, T., Kinosaki, M., Nishimura, Y., Esaki, T., Ogawa, K., Miyake, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms13384 · Cited by 83
Spiropiperidines as high-affinity, selective .sigma. ligands.
Chambers, M. S., Baker, R., Billington, D. C., Knight, A. R., Middlemiss, D. N., & Wong, E. H. F. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00089a013 · Cited by 78
Michaelides, M. R., Kluge, A. F., Patane, M. A., Drie, J. H. V., Wang, C., Hansen, T. M., Risi, R. M., Mantei, R. A., Hertel, C., Karukurichi, K. R., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00395 · Cited by 77
Sjögren's syndrome: Where do we stand, and where shall we go?
Cornec, D., Jamin, C., & Pers, J. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.02.006 · Cited by 75
Steroidal Aldosterone Blockers. II1
Cella, J. A., & Tweit, R. C. (1959) · The Journal of Organic Chemistry · doi:10.1021/jo01090a019 · Cited by 75
Lead Optimization of Spiropyrazolopyridones: A New and Potent Class of Dengue Virus Inhibitors
Zou, B., Chan, W. L., Ding, M., Leong, S. Y., Nilar, S., Seah, P. G., Liu, W., Karuna, R., Blasco, F., Yip, A., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500521r · Cited by 74
Bhattacharya, S. K., Andrews, K., Beveridge, R., Cameron, K. O., Chen, C., Dunn, M., Fernando, D., Gao, H., Hepworth, D., Jackson, V. M., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400473x · Cited by 73
Johansson, A., Löfberg, C., Antonsson, M., von Unge, S., Hayes, M. A., Judkins, R. A., Ploj, K., Benthem, L., Lindén, D., Brodin, P., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01654 · Cited by 70
Pike, V. W., Rash, K. S., Chen, Z., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101487v · Cited by 69
Apalutamide: First Global Approval
Al-Salama, Z. T. (2018) · Drugs · doi:10.1007/s40265-018-0900-z · Cited by 69
Hamdouchi, C., Kahl, S. D., Lewis, A. P., Cardona, G. R., Zink, R. W., Chen, K., Eessalu, T. E., FICORILLI, J. V., Marcelo, M. C., Otto, K. A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00892 · Cited by 67
Morciano, G., Preti, D., Pedriali, G., Aquila, G., Missiroli, S., Fantinati, A., Caroccia, N., Pacifico, S., Bonora, M., Talarico, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00278 · Cited by 60
Active Site Ring‐Opening of a Thiirane Moiety and Picomolar Inhibition of Gelatinases
Forbes, C. C., Shi, Q., Fisher, J. F., Lee, M., Hesek, D., Llarrull, L. I., Tóth, M., Gossing, M., Fridman, R. A., & Mobashery, S. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00881.x · Cited by 59
Ratni, H., Rogers‐Evans, M., Bissantz, C., Grundschober, C., Moreau, J., Schuler, F., Fischer, H., Sánchez, R. A., & Schnider, P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501745f · Cited by 54
Reilly, S. W., Puentes, L. N., Wilson, K., Hsieh, C., Weng, C.-C., Makvandi, M., & Mach, R. H. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00576 · Cited by 51
Spirocycles as Rigidified sp3-Rich Scaffolds for a Fragment Collection
Sveiczer, A., North, A. J. P., Mateu, N., Kidd, S. L., Sore, H. F., & Spring, D. R. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b01499 · Cited by 49
Mould, D. P., Alli, C., Bremberg, U., Cartic, S., Jordan, A. M., Geitmann, M., Maiqués-Díaz, A., McGonagle, A. E., Somervaille, T. C. P., Spencer, G. J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00462 · Cited by 48
Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?
Panza, F., Lozupone, M., Watling, M. I. L., & Imbimbo, B. P. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1621751 · Cited by 45
King, T. A., Stewart, H. L., Mortensen, K. T., North, A. J. P., Sore, H. F., & Spring, D. R. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900847 · Cited by 44
Hip To Be Square: Oxetanes as Design Elements To Alter Metabolic Pathways
Toselli, F., Fredenwall, M., Svensson, P., Li, X., Johansson, A., Weidolf, L. O. G., & Hayes, M. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00030 · Cited by 44
Discovery of Novel Antigiardiasis Drug Candidates
Kulakova, L., Galkin, A. G., Chen, C. Z., Southall, N. T., Marugán, J., Zheng, W., & Herzberg, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03834-14 · Cited by 41
Morgen, M., Jöst, C., Malz, M., Janowski, R., Niessing, D., Klein, C. D. P., Gunkel, N., & Miller, A. K. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00755 · Cited by 38
García, M., Virgili, M., Alonso, M., Alegret, C., Fernández, B., Port, A., Pascual, R., Monroy, X., Vidal‐Torres, A., Serafini, M. T., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01256 · Cited by 38
Hughes, D. L. (2020) · Organic Process Research & Development · doi:10.1021/acs.oprd.0c00005 · Cited by 38
Cianchetta, G., Stouch, T. R., Yu, W., Shi, Z.-C., Tari, L. W., Swanson, R. V., Hunter, M. J., Hoffman, I., & Liu, Q. (2010) · Current Chemical Genomics · doi:10.2174/1875397301004010019 · Cited by 37
Evaluating the Advantages of Using 3D-Enriched Fragments for Targeting BET Bromodomains
Johnson, J. A., Nicolaou, C. A., Kirberger, S. E., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00414 · Cited by 36
Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors
Goldberg, D. R., Lombaert, S. D., Aiello, R. J., Bourassa, P., Barucci, N., Zhang, Q., Paralkar, V. M., Stein, A. J., Holt, M. C., Valentine, J., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.12.053 · Cited by 33
Sherwood, A. M., Crowley, R. S., Paton, K. F., Biggerstaff, A., Neuenswander, B., Day, V. W., Kivell, B. M., & Prisinzano, T. E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00148 · Cited by 31
Tai, V. W. ‐., Garrido, D. M., Price, D. J., Maynard, A. T., Pouliot, J. J., Xiong, Z. Z., Seal, J. W., Creech, K. L., Kryn, L. H., Baughman, T. M., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.080 · Cited by 29
Cruz, J. C., Thomas, M., Wong, E., Ohgami, N., Sugii, S., Curphey, T. J., Chang, C. C. Y., & Chang, T. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200015-jlr200 · Cited by 27
Schwertz, G., Witschel, M. C., Rottmann, M., Leartsakulpanich, U., Chitnumsub, P., Jaruwat, A., Amornwatcharapong, W., Ittarat, W., Schäfer, A., Aponte, R. A., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800053 · Cited by 27
Rudd, M. T., Butcher, J. W., Nguyen, K. T., McIntyre, C. J., Romano, J. J., Gilbert, K. F., Bush, K. J., Liverton, N. J., Holloway, M. K., Harper, S., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201402558 · Cited by 24
Tacke, R., Bertermann, R., Burschka, C., Dorrich, S., Fischer, M., Müller, B., Meyerhans, G., Schepmann, D., Wünsch, B., Árnason, I., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100423 · Cited by 23
Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors
Zhao, Z., Pissarnitski, D. A., Josien, H. B., Wu, W., Xu, R., Li, H., Clader, J. W., Burnett, D. A., Terracina, G., Hyde, L. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00774 · Cited by 22
Norpiperidine Imidazoazepines as a New Class of Potent, Selective, and Nonsedative H1 Antihistamines
Janssens, F. E., Leenaerts, J., Diels, G., Boeck, B. D., Megens, A. A. H. P., Langlois, X., van Rossem, K., Beetens, J. R., & Borgers, M. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049495j · Cited by 22
Adams, B. T., Niccoli, S., Chowdhury, M. A., Esarik, A. N. K., Lees, S. J., Rempel, B. P., & Phenix, C. P. (2015) · Chemical Communications · doi:10.1039/c5cc03828f · Cited by 20
Reilly, S. W., Riad, A., Hsieh, C., Sahlholm, K., Jacome, D. A., Griffin, S. A., Taylor, M., Weng, C.-C., Xu, K., Kirschner, N., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00412 · Cited by 20
Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors
Goldberg, D. R., Lombaert, S. D., Aiello, R. J., Bourassa, P., Barucci, N., Zhang, Q., Paralkar, V. M., Valentine, J. J., & Zavadoski, W. J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.064 · Cited by 18
Multigram Synthesis of Functionalized Spirocyclic Diazirines
Martyloga, O. V., Myronenko, A., Tkachenko, A. M., Matvienko, V. O., Kuchkovska, Y. O., & Grygorenko, O. O. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900485 · Cited by 16
Fragment-Based Discovery of Novel Potent Sepiapterin Reductase Inhibitors
Alen, J., Schade, M., Wagener, M., Frank, C., Nordhoff, S., Merla, B., Dunkern, T. R., Bahrenberg, G., & Ratcliffe, P. D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00218 · Cited by 16
Naidu, B. N., Walker, M. A., Sorenson, M. E., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.027 · Cited by 15
Designed Spiroketal Protein Modulation
Scheepstra, M., Andrei, S. A., Ünver, M. Y., Hirsch, A. K. H., Leysen, S., Ottmann, C., Brunsveld, L., & Milroy, L. ‐. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201612504 · Cited by 14
Natsutani, I., Iwata, R., Yamai, Y., Ishida, K., Nagaoka, Y., & Sumiyoshi, T. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13496 · Cited by 13
Volgraf, M., Chan, L., Huestis, M. P., Purkey, H. E., Burkard, M., Geck, M., Harris, J., Hunt, K. W., Liu, X., Lyssikatos, J. P., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.012 · Cited by 12
Schröder, S. P., Kallemeijn, W. W., Debets, M. F., Hansen, T., Sobala, L. F., Hakki, Z., Williams, S. J., Beenakker, T. J. M., Aerts, J. M. F. G., van der Marel, G. A., et al. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201801902 · Cited by 11
Chao, W., Chiang, T., Chaudhari, P. D., Lin, L., Lu, J., Hong, B., Wang, J.-S., Lin, T.-C., Shen, J., & Chou, P. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.09.006 · Cited by 7
Ren, A., Zhu, X., Feichtinger, K., Lehman, J., Kasem, M., Schrader, T. O., Wong, A. S., Dang, H., Le, M., Frazer, J. M., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126929 · Cited by 6
Cited by
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Enantioselective electrochemical cobalt-catalyzed aryl C–H activation reactions
von Münchow, T., Dana, S., Xu, Y., Yuan, B., & Ackermann, L. (2023) · Science · doi:10.1126/science.adg2866 · Cited by 299
Metadata
- Authors
- Hiesinger, K., Dar’in, D., Proschak, E., & Krasavin, M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-12-31
- Volume
- 64
- Issue
- 1
- Pages
- 150-183
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3113624232
- Cited by
- 618
- References
- 82
- FWCI
- 20.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.